Volume 10, Issue 3 March, 2002
Published by Ag-West Biotech Inc.
Researchers discovering synchrotron potential
Many researchers in the life sciences may not yet realize that a synchrotron is a tool that
This is rapidly changing, according to Rob Slinger, Chief Business Development Officer
of Canadian Light Source Inc. (CLS), a subsidiary of the University of Saskatchewan set
up to manage the $174-million facility.
―We‘re at the ‗inform them what it is‘ stage,‖ he says. ―It‘s essentially a new tool ..., and
it‘s only in the last decade that we‘ve refined it and learned how to use it.‖
Construction on the CLS is slated for completion in 2004. However, work is already
being done to get the expertise in place to use the facility when the first beamlines are
activated. This is being done both through hiring by various institutions and by training
Building collaborative research teams
Slinger says this training begins by locating researchers with a problem suited to
synchrotron application – and there are many. The next step is to help build a team. For
example, if a scientist is looking at heavy metal uptake in plants for phytoremediation of
contaminated soils, CLS staff can find collaborators, design experiments, and book
beamline time on one of the existing facilities in North America or abroad.
―You want to identify research proposals, talk to our team members, and find out where
we can add value to your research programs,‖ Slinger says.
For those who aren‘t sure where to start, CLS staff can recommend workshops,
seminars, and conference events world wide to help build a basic knowledge of
synchrotrons and their applications. Slinger stresses that while this powerful tool may be
unfamiliar, it‘s well within the grasp of the average scientist.
―Anybody that knows their way around an analytical lab has the potential to use
synchrotrons,‖ he says. ―You learn by doing.‖
Agriculture, life science applications closely linked
Synchrotron light has a wide variety of applications in the life sciences, many of which
have crossover implications. For example, U of S scientists are using the tool to examine
sulfur, carbon, and other elements in soils. The research has implications at a practical
level for the farmer, as the research may reveal how to best use fertilizers. It also may
shed light on soils as carbon sinks in the global warming equation, and help understand
how microorganisms interact to contribute to healthy topsoil.
Dr. Colleen Christensen manages the Biomedical Imaging Beamline project, launched
to build a beamline devoted to life sciences. She explains that synchrotron light can be an
imaging tool without equal, offering clear pictures of biological structures that are either
invisible or indistinct using other imaging techniques.
―This is something where you can see soft tissue interfaces, and you can see them in
vivo, so it has tremendous applications in animal sciences and plant sciences as well.‖
A next generation imaging tool
A major advantage of the synchrotron is the ability to study plants and animals without
damaging the subject. Christensen explains traditional imaging tools require that the
researcher take biopsies or euthanize the subject animal in order to study it. Not only does
this destroy the test subject, it limits the results to one ―snapshot‖ in time. Also, dyes used
in imaging can alter the sample.With synchrotron light, research can be done in vivo, over
time, allowing both longitudinal and repeated measure studies. This provides researchers
with a new window into life processes, from the activity at the edges of internal organs to
the perfusion of fluids through plant cell walls.
―If you have the appropriate detector, you can see the edges of cells,‖ Christensen says.
―It‘s absolutely the next generation of imaging tool.‖
Learning to ask the right question
The Biomedical Imaging Beamline project was initiated late in 2001 by a consortium
including Saskatoon District Health, the University of Saskatchewan, and the Canadian
Light Source Inc. So far, the group has gathered support from scores of researchers,
departments, and institutions across the country, including every veterinary college in
Canada. Over 30 abstracts of specific research proposals for the beamline have also been
The CLS Facilities Advisory Committee must now review these proposals to build the
beamline. If the project is approved and funded, it should be operational by 2006.
Christensen says researchers needn‘t wait that long. The first beamlines coming online
in 2004 will be able to provide some answers.
―In agbiotech, there are people that will use every possible beamline,‖ she says. ―There
is no such thing as an animal beamline or plant beamline; it is simply a matter of the
question that the researcher is asking.‖
More information at http://www.lightsource.ca/, or Kathryn Warden at 306-966-2506. Related
item page 8.
An Introduction to the Science of Biotechnology
Two-day workshop April 29 – 30, 2002
If you have ever wondered about the dynamic world of biotechnology or wanted to understand the science
behind some of today‘s most amazing innovations then this workshop is for you.
Learn about the various applications of biotechnology in health care, agriculture, environment,
forestry, food, and aquaculture.
Where: Innovation Place, Atrium Building,
Candle and Span Rooms,
111 Research Drive, Saskatoon, SK S7N 3R2
Cost: $750 + GST
Get more information/Register on line at
Biotechnology Human Resource Council
Tel: 613-235-1402 ext: 614
Brought to you by Biotechnology Human Resource Council in partnership with Ag-West Biotech Inc.
GLOBAL BUSINESS POTENTIAL IN SASKATCHEWAN CANADA
Peter McCann, President, Ag-West Biotech Inc.
In a recent visit to Europe that included Berlin, Munich, Amsterdam, Dusseldorf, and
Zurich, it quickly became apparent that many European biotechnology companies could
benefit substantially from looking to Saskatchewan, Canada as a place to develop biotech
products for global markets.
Many companies, governments, universities, and private research institutions have
realized the tremendous potential offered by technologies for the production of
therapeutic molecules in plants and in animals. Low cost, safe production of gram and
kilogram quantities of therapeutic products can be achieved either in closed production
systems such as the underground growth chambers of Prairie Plant Systems or in
greenhouses. Other products can be produced in the field, under carefully controlled
conditions. Examples already exist of cytokines, anti-bodies, blood proteins including
haemoglobin, and certain vaccines being produced or being very close to commercial
production in planta in Saskatchewan and elsewhere.
Many European biotech companies have developed similar, sometimes more advanced
technologies, but are unable to commercialize them due to restrictive EU regulations
around GMOs. Saskatchewan, Canada offers an ideal location in which to commercialize
these technologies into products that will generate revenues from new markets, in North
America and around the world.
KPMG recently ranked Saskatoon fourth globally in its ability to attract and retain
biomedical R&D business. Its infrastructure is designed specifically to support
commercialization as well as R&D. With one of the world‘s best R&D tax credit regimes,
one dollar invested costs only forty cents! Saskatchewan boasts having one of the lowest
operating costs in any developed country – a small biotech organization with three
scientists and three support staff, an office, lab, and greenhouse can be operated at a net
annual cost of 200,000 Euros in Innovation Place, the world famous research park at
University of Saskatchewan.
Saskatchewan offers a secure, safe, supportive, and very progressive environment in
which to do business. A European company taking advantage of this by locating a
presence here can develop products to market readiness, launch the products and generate
revenues in North America while gaining a wealth of practical operating experience. This
business know-how can be transferred back to Europe when regulatory and other market
conditions improve, resulting in a real commercial benefit for companies that have the
foresight to take advantage of this exciting opportunity.
Ag-West Biotech Inc. is your single window of support for all types of biotech business
Give us a call at 306-975-1939, or check out our web site at http://www.agwest.sk.ca
Still more work needed on the GM food labelling standard
The Canadian General Standards Board (CGSB) Committee set up to draft a national
standard for the voluntary labelling of genetically modified food did not achieve
consensus when the draft standard was put to its first vote. The draft standard was
circulated to the 53 voting members of the Committee – representing producer, user, and
general interest groups – at the end of December 2001. The results were released to the
committee in mid-February. The outcome was 51% percent voted for the standard in its
current form, 36% voted against it, and 5% abstained. Fifty-one ballots were returned for
a response rate of 96%.
BIOTECanada was among the groups that supported the draft standard. They believe
that the draft represented an acceptable and workable compromise between the various
positions represented. BIOTECanada is committed to working with the other Committee
members to resolve the outstanding issues and finalize a labelling standard that will
provide consumers with labels that are understandable, informative, not false, and not
misleading – the key principles endorsed by the Committee.
The Committee‘s work is driven by consensus, which is defined as substantial
agreement by those involved. Efforts are made to resolve the concerns of those who
submit negative votes. The Committee will continue these efforts at its next meeting
March 6-8, 2002 in Ottawa. This standard development process is sponsored by the
Canadian Council of Grocery Distributors and facilitated by the Canadian General
Andrew McColgan, Manager, Policy and Public Affairs for BIOTECanada, and a
member of this CGSB Committee can be reached at AMcColgan@BIOTECH.ca.
New vaccine offers broad protection for livestock
Livestock producers may soon be able to give their animals broad-spectrum protection
against bacterial infections thanks to research at the Veterinary Infectious Disease
Organization in Saskatoon (VIDO).
Using a mixture of synthetic bacterial DNA, a team led by Dr. George Mutwiri elicited a
broad immune system response. The approach capitalizes on structural differences
between mammalian and bacterial DNA to prime the body‘s defenses.
―This structural difference is recognized as a ‗danger‘ signal by the immune system,‖
Mutwiri says. ―A response is triggered that heightens defenses against a number of
In a few years, the broad-spectrum immunostimulant could offer a new way to manage
disease. For example, farmers could protect their animals when they don‘t know what to
expect, such as when new stock arrives at a feedlot. So far, the research focus has been on
cattle, but swine and poultry are also being studied. For now, Mutwiri and his team are
working out optimum dosages for the immunostimulant, which will initially be delivered
by injection. Eventually, it may be administered by intranasal spray or another of the
alternative systems currently under development at VIDO.
For more information, visit http://www.vido.org/, or call Stuart Bond at 306-966-7474.
Bacteria that normally make a living munching carbon compounds at the bottom of the
sea could find new work in bioremediation, with an added bonus — electricity.
In the wild, the bugs strip electrons from carbon in ocean sediments as they convert it
into the carbon dioxide they need to live. Normally, these electrons get dumped on
whatever iron or sulphate minerals are lying around. However, researchers at Oregon
State University discovered the bacteria will also pile the electrons onto an electrode.
Stick one electrode in the ocean sediment and another in the water above, and you‘ve got
The phenomenon might provide power for low-draw navigational devices that monitor
water current and temperature.
Back on land, researchers from the University of Massachusetts isolated the family of
bacteria responsible for the power: Geobacteraceae. They also found some fresh water
species that can do the same thing, offering another possible route to cleaning up oil spills
or petroleum contaminated water, while producing a little power at the same time.
Source: Nature Science Update, http://www.nature.com/nsu/020114/020114-9.html
Fuel ethanol in Saskatchewan
The Saskatchewan Agrivision Corporation Inc. Hibernia Strategy Task Force presented
the Real World of Ethanol Conference on January 30, 2002 in Saskatoon. The conference
focused on the potential development of an ethanol industry for Saskatchewan.
The lineup of presenters included a video message from federal Minister of the Crown,
Ralph Goodale and the Minister for Saskatchewan Energy and Mines, Andrew Thompson
provided opening remarks. Lionel LaBelle, Coordinator, SAC Inc. Ethanol Task Force
presented the task force‘s Preliminary Report on Saskatchewan‘s Hibernia (Ethanol)
Strategy. Bob Ness, Chair, Agricultural Committee, Minnesota State shared the history of
mandated ethanol use in the state. Margaret Bailey, Chief, Fuels Policy & Programs,
Natural Resources Canada discussed the role of national and regional governments in the
ethanol industry. Other presenters touched on petroleum market issues and the role of
corporate and community investors.
Following up on the conference the task force has recently released a report projecting
that with an aggressive and targeted plan of action, Saskatchewan could increase it‘s
ethanol production capacity nearly 19 fold over the next five years.
SAC Inc. is a coalition of farm and business leaders with a mandate to establish a clear
vision for the rapid growth of value-added processing throughout Saskatchewan. By
uniting all players, from suppliers through to farmers, transporters, and retailers, SAC
Inc. encourages and fosters the rapid development of Saskatchewan‘s agribusiness sector.
Conference presentations and the task force report are available at:
The World Bank for barley and oat
Two vaults in Saskatoon house thousands of manila or sealed aluminum envelopes,
together holding a treasure whose worth is still to be determined. The temperature and
humidity controlled vaults at Agriculture and Agri-Food Canada‘s Saskatoon Research
Centre are the repository for Plant Gene Resources of Canada (PGRC). Together, they
hold the world‘s largest collection of seeds from the genera Hordeum and Avena – barley
PGRC was created in the 1970s through an agreement between the Canadian
government and the International Plant Genetic Resource Institute (IPGRI) in Rome,
Italy. The assignment: to safeguard the genetic resources of these two crops for the world.
―Over the years, Canada has been relatively aggressive in acquiring barley and oat
germplasm,‖ says PGRC Manager, Dr. Ken Richards. Now, the collection includes over
38,000 Hordeum samples and about 28,000 Avena samples from as far away as Greece
and Italy. Both cultivated and wild species are included.
Like a financial bank, every deposit earns interest – in the form of knowledge. Part of
keeping the gene bank is regenerating seed, to maintain viable samples. This means
growing out the plants and collecting the seed, all the while taking steps to ensure that it
retains its genetic purity. In the process, researchers gain information that goes into a
Our knowledge of each sample varies greatly. For some, information is scant, while
others, such as those extensively cultivated, are well documented. Hence, the true value
of the gene bank is still to be determined.
―Wild cousins frequently have very desirable traits like drought or disease tolerance,‖
Richards says. ―Part of plant breeding today is to move these traits into cultivated
Richards says that gene banks also act as insurance against new diseases or
environmental conditions. He cites the example of a corn blight that threatened this crop
in the 1970s. Plant breeders incorporated resistance from germplasm from US gene
banks, and the crop was saved.
―It provides insurance against new diseases, or adaptation to changed climate,‖ he says.
―It provides a potentially valuable resource for the unknown – answers people haven‘t
even looked for yet.‖
The PGRC database lists all samples in the gene bank – barley, oat and other species
including tomato, flax, and about 850 others. It features powerful search tools to help
researchers find what they need.
For more information or access to the database, go to http://www.agr.gc.ca/pgrc-rpc.
Recently recognized in Genetic Engineering News‘ list of the Top 100 Sites, this web
site offers basic information about plants with novel traits, including genetically
engineered crop species. It also provides other general agricultural biotechnology related
information as well as links to related world-wide-web resources on this topic.
Agriculture & Biotechnology Strategies Inc. (AGBIOS) is an Ottawa-based company that
is dedicated to providing consulting expertise to the agricultural biotechnology industry,
government departments and agencies, non-governmental organizations, and producer
groups and associations.
Saskatoon’s BioMedical Imaging Group
The BioMedical Imaging Group, formed November 7, 2001, is a unique partnership
between Saskatoon District Health, the University of Saskatchewan (U of S), and the
Canadian Light Source (CLS). This is the first time in history that representatives of these
three groups, applied health care, basic health and lifesciences research, and a third
generation synchrotron, have formed a partnership to develop opportunities in
synchrotron-based research and health care.
―While synchrotron research around the world has historically been associated with the
physical sciences and not the life sciences, more recent work in protein crystallography as
well as soft tissue imaging points the way to major advances in the design of new drugs,
screening for certain cancers, and therapy of inoperable tumors. Without doubt broader
applications will be realized as the full impact of this technology in health care is just
starting to be understood‖ said Barry Maber, Vice President of Research for the
Saskatoon District Health.
The mandate of the BioMedical Imaging Group is to identify and engage academic,
industry, and government researchers involved in biomedical imaging, for the
development of a scientific proposal for synchrotron biomedical imaging at the CLS.
Research priorities within Saskatchewan have been identified and a core group of
researchers has been formed to involve researchers in other provinces, so that the final
scientific proposal has a pan-Canadian perspective.
―Exploring potential new research and development opportunities in life sciences
synchrotron applications is one of the most exciting elements of the synchrotron
development program here at CLS.‖ This initiative will impact the activities of the
Canadian Light Source stated Rob Slinger, Chief Business Development Officer of the
The BioMedical Imaging Group has developed a scientific proposal for review by the
CLS Facilities Advisory Committee in February 2002. Following consideration by the
Facilities Advisory Committee a full technical and financial proposal could be developed.
CLS is considering a package of additional beamlines to be developed into a phase II
project for capital funding options, including a coordinated multibeamline Canada
Foundation for Innovation (CFI) application. The CLS development and recommendation
process ensures that beamlines are built in response to the growing needs of the Canadian
synchrotron science community.
Synchrotron-based BioMedical Imaging provides numerous opportunities for research
and potential clinical applications in imaging and radiation therapy.
―The synchrotron is a diagnostic tool which has tremendous potential in many areas of
biomedical and clinical research.‖ said Barry McLennan, Associate Dean of Research,
College of Medicine, U of S.
With synchrotron-based biomedical imaging there is an extremely high intensity of the
electromagnetic source and a very smooth, broadband energy spectrum, relative to
conventional imaging techniques such as magnetic resonance imaging (MRI), computer-
aided tomography (CT) and positron emission tomography (PET). Because of these
attributes synchrotron-based biomedical imaging has a wide range of developing research
applications including imaging of single cells to whole organs within a living animal,
expanding the fundamental understanding of radiation cell biology, and innovation in
new modalities of clinical imaging. The BioMedical Imaging beamline will include
research from the fields of human and animal productivity and health as well as plant
For more information contact: Dr. Colleen Christensen, Project Manager, BioMedical
Imaging Beamline Group mailto:email@example.com or visit:
THE GM DEBATE MARCHES ON
Lance Wall, Coordinator, Saskatchewan Agricultural Biotechnology Information Centre,
The debate over genetic modification shows little sign of abating. Various stakeholders
in each camp are holding to their views. The middle ground is a little hard to find.
I recently participated as one of five panelists, in a public forum on GM Grains. Panel
members presented various points of view and had the opportunity to respond to
questions from the audience. Views ranged along a continuum from GM technology as
out of control and unnecessary, to GM technology as simply another input tool available
to balance agricultural ecosystems. I emphasized potential benefits and the lack of critical
evidence demonstrating that genetically modified food products present any threat to
human or animal health.
Cathy Holtslander, Coordinator of the Saskatchewan Eco-network and a member of the
Canadian Biotech Action Network, made the point that the technology is not precise –
that modified crops contaminate natural plant species, destroy biodiversity, and
Dr. Graham Scoles, of the University of Saskatchewan, noted that agriculture
ecosystems are not natural, but are systems out of balance. Extensive monoculture does
not promote biodiversity and intensive inputs are required to maintain and balance
agriculture systems. GM technology is another optional agricultural input.
Dr. Richard Cassidy, a U of S professor of ethics in science, discussed the polarization
of the issues concerning GM technology. Using humour to make his point, he stressed
that scientists need to become more sensitive to the concerns expressed about genetic
Hart Haidn, Director of the Canadian Centre for Sustainable Agriculture, Saskatoon,
asked ―Who needs it?‖ in reference to GM technology. He stated underproduction is not
the problem, but that perhaps overproduction is.
Questions from the floor covered topics from social acceptance of the technology,
through concerns for individual and environmental risks, and consumers‘ desire for
Dr. Michael Mehta, of the Department of Sociology, U of S, noted at a recent seminar,
acceptance of GM technology comes more from a trust of science and its institutions. The
institutions involved must regain the public confidence.
All groups involved in the debate do not agree on the road ahead. I believe that we need
to attempt to understand opposing views in the debate. We are all entitled to our own
views and opinions. This is more important than whether our food is GM or not. I
encourage a mature approach – the willingness to debate the issues, attend public forums
and learn more will demonstrate that we care.
Lance Wall can be reached at firstname.lastname@example.org
Mar. 6-7 Superbugs and Superdrugs, London, England
Mar. 11-12 Introduction to the Science of Biotechnology, Toronto, ON Canada
Mar. 18-19 The New York Biotechnology Association’s 11 Annual Meeting New York, NY
Mar. 18-20 AchemAmerica 2002 1 International Exhibition on Chemical Engineering,
Environmental Protection and Biotechnology Mexico City, Mexico
Mar. 19-20 Managing Communications in a Crisis, Saskatoon, SK Canada
Mar. 19-21 Engineering Tissue Growth International Conference and Exposition, Pittsburgh,
PA USA http://www.etgonline.com/
Mar. 20-21 Bio-Tech Israel 2002 Conference, Tel Aviv, Israel http://www.kenes.com/biotech
Mar. 22-23 Synchrotron Applications in Life Sciences, Saskatoon, SK Canada
Mar. 24-26 35 Annual Canola Council of Canada Convention, Vancouver, BC Canada
Mar. 25 4 Annual BC Biotechnology Awards Ceremony, Vancouver, BC Canada
Apr. 3-6 National Agri-Food Awareness Conference 2002 Growing for the Future
Victoria, BC Canada http://www.agaware.bc.ca/
Apr. 16-17 The European Biotech Investment Forum, London, England
Apr. 18-19 Fermentation and Bioprocessing Conference, Melbourne, Australia
Apr. 29-30 An Introduction to the Science of Biotechnology, Saskatoon, SK Canada
May 6-7 The Nanotech & Biotech Convergence 2002, Stamford CT USA
May 11-14 2nd Annual International Conference of the Canadian Proteomics Initiative,
Edmonton, AB Canada http://www.cpi02.org/
May 11-19 Canada-Wide Science Fair, Saskatoon, SK Canada http://www.usask.ca/cwsf/
May 19-23 American Society for Microbiology 102 General Meeting Salt Lake City, UT
May 22-26 IOBC/WPRS-EFPP Working Group: Biological Control of Fungal & Bacterial
Plant Pathogens, Kusadasi, Turkey
June 9-12 Bio 2002, Toronto, ON Canada http://www.bio2002.org/
Saskatoon, SK – Canada’s “Science City” September 15 - 18, 2002
4 Optional Satellite Sessions add to ABIC 2002!
A group of satellite sessions that compliment the ABIC 2002 programs are offered to
add even greater value to your ABIC 2002 experience! Four broad topics have been
established for these satellite sessions:
1. The Canadian Regulatory Perspective: A Science-based Approach to
Safety and Benefits September 15, 8:00 a.m. – 12:30 p.m. Hosted by Ag-West
Biotech Inc. Fee: $100.00
2. The Bio-based Economy: Moving from Concept to Reality September 18,
2:00 – 4:00 p.m. Hosted by Environment Canada and Industry Canada. Fee: no
3. Biotech Communicators: The Interface Between Scientist and Public
September 18, Full-day option: 8:00 a.m. – 5:00 p.m. (Half-day program from 2:00
– 5:00 p.m.) Hosted by Ag-West Biotech Inc. Full-day Fee: $100.00 to ABIC
registrants; $250.00 to other participants. Afternoon session only $100.00.
4. The Multiple Roles of Metabolic Profiling: From Functional Genomics to
Genetic Engineering to Substantive Equivalence, Metabolic Profiling is Integral to
Biotechnology Research September 18, 2:00 – 5:00 p.m. Hosted by Phenomenome
Discoveries Inc. and Ag-West Biotech Inc. Fee: $100.00
Make the most of your trip to Saskatoon and sign up for one or more of these exciting
Check the newly expanded ABIC website at: http://www.abic.net/ for program
developments, speaker profiles, sponsorship opportunities, scientific poster competition,
synchrotron beam time and expertise award, travel bursary, and registration information
or contact: Conference Coordinator, Lucille Richardson at: email@example.com or by phone at:
Ag-West Biotech Board of Directors
Chair: Dr. Pete Desai, President, Desai & Desai Inc.
Vice Chair: Ms. Shelley Brown, Deloitte & Touche
Secretary-Treasurer: Mr. Murray Trapp, President, MicroBio Rhizogen Corp.
Dr. Ernie Barber, Dean, College of Agriculture, University of Saskatchewan
Mr. John Buchan, Director, Crop Development Branch,
Saskatchewan Agriculture and Food
Dr. Malcolm Devine, Global Head of Technology Identification, Assessment
and Acquisition, Aventis CropScience
Dr. Kutty Kartha, Director General, National Research Council-Plant
Mr. Jerome Konecsni, Vice-President Administration,
Bioriginal Food and Science Corp.
Mr. Ian McPhadden, Producer, Milden SK
Dr. Ashley O‘Sullivan, Director, Agriculture and Agri-Food Canada
Saskatoon Research Centre
Dr. Carolyn Weeks-Levy, Vice-President, Research and Development,
Ag-West Biotech Publications
Ag-West Biotech offers several publications at no cost. Please fax your selections to:
306-975-1966, e-mail: firstname.lastname@example.org, or visit: http://www.agwest.sk.ca/
AgBiotech InfoSource – an informative newsletter for schools.
Available electronically at: http://www.agwest.sk.ca/e_infosrc.shtml
Issue 72 – “Biofuels for transportation” is now available
Newtrition – a printed quarterly newsletter for consumers and the food industry
Now available – Winter 2001 Issue – featuring “How can I be sure my food is safe?”
The AgBiotech Bulletin is produced by Ag-West Biotech Inc.
Editor: Judy Hume, Manager of Communications, Ag-West Biotech Inc.
Articles, comments, announcements and subscription requests are welcome. Please send
your enquiries to: email@example.com or fax: 306-975-1966
Peter McCann, President
Ag-West Biotech Inc.
101-111 Research Dr.
Canada S7N 3R2
Web site: http://www.agwest.sk.ca
Readers wishing to have their comments considered for inclusion are encouraged to send
less than 500 words via e-mail to: firstname.lastname@example.org. Include your name and contact
information. We reserve the right to edit for length. J. Hume, Editor
Funding assistance is provided by Saskatchewan Agriculture and Food.